Imaging Studies of Patients with Malignant Fibrous Histiocytoma Using C-11-Alpha-Aminoisobutyric Acid (AIB)
- 1 January 1987
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 12 (1) , 22-26
- https://doi.org/10.1097/00003072-198701000-00005
Abstract
Alpha-aminoisobutyric acid (AIB), a synthetic, nonmetabolized amino acid which is rapidly transported into viable cells by the A-type or alanine-preferring amino acid transport system, has been labeled with the shortlived, positron-emitting radionuclide carbon-11. Carbon-11 labeled AIB is currently being evaluated as a tumor imaging agent for in vivo amino acid transport studies in patients with cancer. In this study, C-11 AIB was used to image two patients with malignant fibrous histiocytoma (MFH), a pleomorphic sarcoma. Following intravenous administration of C-11 AIB, tumors in the distal femur of one patient and in the anterior chest wall of another patient were well visualized using high energy gamma scintigraphy. Since therapy may alter the accumulation of amino acids in tumor tissue, studies using C-11 AIB in patients with MFH before and after chemotherapy are in progress.This publication has 6 references indexed in Scilit:
- Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 casesCancer, 1984
- Synthesis and quality assurance of [11C]alpha-aminoisobutyric acid (AIB), a potential radiotracer for imaging and amino acid transport studies in normal and malignant tissuesInternational Journal of Nuclear Medicine and Biology, 1984
- Adjuvant chemotherapy of malignant fibrous histiocytoma of boneCancer, 1983
- Imaging of primary Ewing sarcoma with 13N-L-glutamate.Radiology, 1982
- IMAGING OF THE HUMAN-HEART AFTER ADMINISTRATION OF L-(N-13)GLUTAMATE1980
- Malignant fibrous histiocytoma.An Analysis of 200 CasesCancer, 1978